Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - OPERATING EXPENSES
Operating Expenses PTGX - Protagonist Therapeutics, Inc.
154 M
LAST VALUE
0.15%
2 YEAR CAGR
15.99%
5 YEAR CAGR
0.00%
10 YEAR CAGR